Pages that link to "Q41856555"

The following pages link to Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization (Q41856555):

Displaying 28 items.

• The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study (Q30407178) (← links)
• Non-surgical treatment of hepatocellular carcinoma (Q34539241) (← links)
• Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. (Q34606217) (← links)
• Hepatocellular carcinoma with adjacent organ extension: the enhancement of preoperative transcatheter arterial embolization and the results of surgical resection (Q40614594) (← links)
• A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma (Q41027374) (← links)
• Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms (Q42106397) (← links)
• Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography (Q42479758) (← links)
• Retrospective evaluation of tumor-mass-reduction therapy for the prognosis of recurrent hepatocellular carcinoma (Q42606941) (← links)
• Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study (Q43824320) (← links)
• Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma (Q46165613) (← links)
• Regression and therapy-resistance of primary liver tumors and liver metastases after regional chemotherapy and local tumor ablation (Q46366359) (← links)
• Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma (Q46838264) (← links)
• Role of intratumoral infiltrating macrophages after transarterial immunoembolization for hepatocellular carcinoma (Q47865300) (← links)
• Histological assessment of combined chemoembolization and alcoholization [corrected] for hepatocellular carcinoma in cirrhotic patients (Q49173421) (← links)
• Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. (Q52372494) (← links)
• Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization: comparison of contrast-enhanced sonography and 3-phase computed tomography. (Q53545241) (← links)
• Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma following Transarterial Chemoembolization: Is It Helpful for Tumor Response? (Q58802980) (← links)
• Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinoma (Q67507645) (← links)
• Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patients (Q67913757) (← links)
• Usefulness of pulsed doppler ultrasound in detection of angiographically evident recurrence of hepatocellular carcinoma after arterial embolization treatment (Q67913760) (← links)
• Portal vein embolization with steel coils and absolute ethanol: a comparative experimental study with canine liver (Q71565029) (← links)
• Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma (Q72018872) (← links)
• Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma (Q72314393) (← links)
• Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma (Q73764961) (← links)
• New therapy complementary to transcatheter arterial embolization for hepatocellular carcinoma (Q73851514) (← links)
• Non‐surgical treatment of hepatocellular carcinoma (Q73960645) (← links)
• Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT) (Q74343780) (← links)
• Long-term follow-up arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma (Q77839497) (← links)